19-1784836-T-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_138813.4(ATP8B3):āc.3643A>Cā(p.Lys1215Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: not found (cov: 33)
Exomes š: 6.9e-7 ( 0 hom. )
Failed GnomAD Quality Control
Consequence
ATP8B3
NM_138813.4 missense
NM_138813.4 missense
Scores
1
18
Clinical Significance
Conservation
PhyloP100: 0.247
Genes affected
ATP8B3 (HGNC:13535): (ATPase phospholipid transporting 8B3) The protein encoded by this gene belongs to the family of P-type cation transport ATPases, and to the subfamily of aminophospholipid-transporting ATPases. The aminophospholipid translocases transport phosphatidylserine and phosphatidylethanolamine from one side of a bilayer to the other. This gene encodes member 3 of phospholipid-transporting ATPase 8B; other members of this protein family are located on chromosomes 1, 15 and 18. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Apr 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.15176606).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP8B3 | NM_138813.4 | c.3643A>C | p.Lys1215Gln | missense_variant | 28/29 | ENST00000310127.10 | NP_620168.1 | |
ATP8B3 | NM_001178002.3 | c.3532A>C | p.Lys1178Gln | missense_variant | 28/29 | NP_001171473.1 | ||
ATP8B3 | NR_047593.3 | n.4026A>C | non_coding_transcript_exon_variant | 28/29 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP8B3 | ENST00000310127.10 | c.3643A>C | p.Lys1215Gln | missense_variant | 28/29 | 1 | NM_138813.4 | ENSP00000311336.6 | ||
ATP8B3 | ENST00000525591.5 | c.3532A>C | p.Lys1178Gln | missense_variant | 28/29 | 1 | ENSP00000437115.1 | |||
ATP8B3 | ENST00000531925.5 | n.*3526A>C | non_coding_transcript_exon_variant | 28/29 | 2 | ENSP00000444334.1 | ||||
ATP8B3 | ENST00000531925.5 | n.*3526A>C | 3_prime_UTR_variant | 28/29 | 2 | ENSP00000444334.1 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD3 genomes
Cov.:
33
GnomAD3 exomes AF: 0.00000423 AC: 1AN: 236536Hom.: 0 AF XY: 0.00000779 AC XY: 1AN XY: 128448
GnomAD3 exomes
AF:
AC:
1
AN:
236536
Hom.:
AF XY:
AC XY:
1
AN XY:
128448
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 6.87e-7 AC: 1AN: 1455216Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 723076
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
AC:
1
AN:
1455216
Hom.:
Cov.:
30
AF XY:
AC XY:
1
AN XY:
723076
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 33
GnomAD4 genome
Cov.:
33
ExAC
AF:
AC:
1
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 09, 2023 | The c.3643A>C (p.K1215Q) alteration is located in exon 28 (coding exon 27) of the ATP8B3 gene. This alteration results from a A to C substitution at nucleotide position 3643, causing the lysine (K) at amino acid position 1215 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
DEOGEN2
Benign
T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
N
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;.
PrimateAI
Benign
T
PROVEAN
Benign
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
P;.
Vest4
MutPred
Loss of methylation at K1215 (P = 0.0058);.;
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at